These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
799 related items for PubMed ID: 9366391
1. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. Cameron MJ, Arreaza GA, Zucker P, Chensue SW, Strieter RM, Chakrabarti S, Delovitch TL. J Immunol; 1997 Nov 15; 159(10):4686-92. PubMed ID: 9366391 [Abstract] [Full Text] [Related]
2. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes. Trembleau S, Penna G, Gregori S, Gately MK, Adorini L. Eur J Immunol; 1997 Sep 15; 27(9):2330-9. PubMed ID: 9341777 [Abstract] [Full Text] [Related]
3. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse. Gallichan WS, Balasa B, Davies JD, Sarvetnick N. J Immunol; 1999 Aug 01; 163(3):1696-703. PubMed ID: 10415077 [Abstract] [Full Text] [Related]
4. Cytokine- and costimulation-mediated therapy of IDDM. Cameron MJ, Arreaza GA, Delovitch TL. Crit Rev Immunol; 1997 Aug 01; 17(5-6):537-44. PubMed ID: 9419441 [Abstract] [Full Text] [Related]
6. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker. Lejon K, Fathman CG. J Immunol; 1999 Nov 15; 163(10):5708-14. PubMed ID: 10553102 [Abstract] [Full Text] [Related]
7. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide. Qin HY, Singh B. J Autoimmun; 1997 Jun 15; 10(3):271-8. PubMed ID: 9218754 [Abstract] [Full Text] [Related]
8. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis. Rothe H, Hausmann A, Casteels K, Okamura H, Kurimoto M, Burkart V, Mathieu C, Kolb H. J Immunol; 1999 Aug 01; 163(3):1230-6. PubMed ID: 10415018 [Abstract] [Full Text] [Related]
9. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent. Tisch R, Wang B, Serreze DV. J Immunol; 1999 Aug 01; 163(3):1178-87. PubMed ID: 10415012 [Abstract] [Full Text] [Related]
10. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy. Tian B, Hao J, Zhang Y, Tian L, Yi H, O'Brien TD, Sutherland DE, Hering BJ, Guo Z. Transplantation; 2009 Jan 27; 87(2):198-206. PubMed ID: 19155973 [Abstract] [Full Text] [Related]
11. [Effects of pravastatin in prevention of diabetes and mechanism thereof: experiment with non-obese diabetic mice]. Zhang S, Yan X, Zhou PC, Huang C, Yang L, Li X, Lin J, Zhou ZG. Zhonghua Yi Xue Za Zhi; 2008 Feb 26; 88(8):568-72. PubMed ID: 18649776 [Abstract] [Full Text] [Related]
12. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice. Han HS, Jun HS, Utsugi T, Yoon JW. J Autoimmun; 1996 Jun 26; 9(3):331-9. PubMed ID: 8816968 [Abstract] [Full Text] [Related]
13. NOD fetal thymus organ culture: an in vitro model for the development of T cells involved in IDDM. Wilson SS, DeLuca D. J Autoimmun; 1997 Oct 26; 10(5):461-72. PubMed ID: 9376074 [Abstract] [Full Text] [Related]
14. Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse. Herbelin A, Gombert JM, Lepault F, Bach JF, Chatenoud L. J Immunol; 1998 Sep 01; 161(5):2620-8. PubMed ID: 9725264 [Abstract] [Full Text] [Related]
15. Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes. Pankewycz O, Strom TB, Rubin-Kelley VE. Eur J Immunol; 1991 Apr 01; 21(4):873-9. PubMed ID: 1902177 [Abstract] [Full Text] [Related]
16. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes. Ott PA, Anderson MR, Tary-Lehmann M, Lehmann PV. Cell Immunol; 2005 May 01; 235(1):1-11. PubMed ID: 16122720 [Abstract] [Full Text] [Related]
17. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, Naidenko OV, Kronenberg M, Koezuka Y, Delovitch TL, Gombert JM, Leite-De-Moraes M, Gouarin C, Zhu R, Hameg A, Nakayama T, Taniguchi M, Lepault F, Lehuen A, Bach JF, Herbelin A. Nat Med; 2001 Sep 01; 7(9):1057-62. PubMed ID: 11533711 [Abstract] [Full Text] [Related]
18. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. Balasa B, Krahl T, Patstone G, Lee J, Tisch R, McDevitt HO, Sarvetnick N. J Immunol; 1997 Nov 01; 159(9):4620-7. PubMed ID: 9379064 [Abstract] [Full Text] [Related]
19. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy. Qin HY, Elliott JF, Lakey JR, Rajotte RV, Singh B. J Autoimmun; 1998 Dec 01; 11(6):591-601. PubMed ID: 9878081 [Abstract] [Full Text] [Related]
20. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis. Matsumoto M, Yagi H, Kunimoto K, Kawaguchi J, Makino S, Harada M. Cell Immunol; 1993 Apr 15; 148(1):189-97. PubMed ID: 8098666 [Abstract] [Full Text] [Related] Page: [Next] [New Search]